Anifrolumab, an Anti-Interferon-a Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus.

Anifrolumab, an Anti-Interferon-a Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus. Arthritis Rheumatol. 2017 02; 69(2):376-386.

View in: PubMed

subject areas

Adolescent
Adolescent
Adult
Adult
Aged
Aged
Antibodies, Monoclonal
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Humanized
Double-Blind Method
Double-Blind Method
Female
Female
Humans
Humans
Lupus Erythematosus, Systemic
Lupus Erythematosus, Systemic
Male
Male
Middle Aged
Middle Aged
Receptor, Interferon alpha-beta
Receptor, Interferon alpha-beta
Severity of Illness Index
Severity of Illness Index
Young Adult
Young Adult

authors with profiles

Joan Merrill